Halozyme Therapeutics, Inc.

CIBC Asset Management Inc HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

3,966

Value ($000)

267

Weight

0.0%

2020 Q4 - 2025 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	267	0.0%	3,966	12/31/2025
2025 Q3	10/31/2025	291	0.0%	3,966	9/30/2025
2025 Q2	8/14/2025	206	0.0%	3,966	6/30/2025
2025 Q1	5/13/2025	253	0.0%	3,966	3/31/2025
2024 Q3	11/6/2024	211	0.0%	3,691	9/30/2024
2022 Q4	2/13/2023	207	0.0%	3,641	12/31/2022
2022 Q3	11/3/2022	224	0.0%	5,660	9/30/2022
2022 Q2	8/9/2022	249	0.0%	5,660	6/30/2022
2022 Q1	5/6/2022	242	0.0%	6,074	3/31/2022
2021 Q4	2/8/2022	244	0.0%	6,074	12/31/2021
2021 Q3	11/9/2021	235	0.0%	5,789	9/30/2021
2021 Q2	8/16/2021	228	0.0%	5,031	6/30/2021
2021 Q1	5/14/2021	210	0.0%	5,031	3/31/2021
2020 Q4	2/3/2021	245	0.0%	5,747	12/31/2020